Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
Pfizer says RSV shot to protect infants may be available by 2023-24 cold and flu season
3 years ago
Pharma
CMS to work closely with FDA on accelerated approval payment reforms
3 years ago
Law
FDA to take another look at Akebia's rejected kidney drug
3 years ago
Pharma
Alnylam gets an adcomm for Onpattro treatment in ATTR amyloidosis
3 years ago
Astellas' menopause drug hit by FDA delay after spending $97M on a priority review voucher
3 years ago
R&D
FDA clears Travere’s rare kidney disease drug, will come with REMS program
3 years ago
Pharma
FDA approves Apellis' retinal disease drug as competitor expects August decision
3 years ago
Pharma
FDA's No. 2 oncology official departs for biotech startup
3 years ago
People
FDA accepts Iveric Bio's NDA, grants priority review for GA drug
3 years ago
R&D
Merck seeks more approvals for infectious disease drug
3 years ago
R&D
FDA gives the OK to Chiesi for treatment of ultra-rare enzyme deficiency disease
3 years ago
Pharma
UK could allow reciprocal drug approvals with US FDA as soon as 2024
3 years ago
Pharma
Over-the-counter Narcan gets unanimous thumbs-up from FDA advisors
3 years ago
Pharma
Moderna promises to provide vaccines at no out-of-pocket cost
3 years ago
Pharma
Coronavirus
Thousands of gene and cell therapies are inundating FDA reviewers as the agency tries to keep up
3 years ago
Pharma
Cell/Gene Tx
FDA to review Galera’s drug for radiotherapy complication, biotech immediately seeks $30M
3 years ago
R&D
In a first, CMS will test paying less for drugs cleared via accelerated approval
3 years ago
Pharma
FDA revises action on compounded ibuprofen, citing oral version shortage
3 years ago
Law experts argue that abortion drug withdrawal would 'undermine' the approval process
3 years ago
Law
Updated: FDA adds warning of 'larger areas of bleeding' in brain to Biogen's Aduhelm label
3 years ago
FDA hands down RTF letter to rare disease biotech's lead candidate
3 years ago
R&D
Should Narcan spray be sold over the counter? FDA poses potential packaging changes
3 years ago
Pharma
Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication
3 years ago
Pharma
Manufacturing
FDA rejects Biocon and Viatris' Avastin biosimilar after inspection question marks
3 years ago
Pharma
First page
Previous page
61
62
63
64
65
66
67
Next page
Last page